Donada C[au] - Search Results

Year	Number of Results
1986	1
1987	1
1988	1
1990	3
1993	2
1995	3
1996	3
1997	3
1998	3
1999	2
2000	3
2001	1
2003	1
2004	1
2005	1
2011	1
2024	0

1

Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype.

Roffi L, Redaelli A, Colloredo G, Minola E, Donada C, Picciotto A, Riboli P, Del Poggio P, Rinaldi G, Paris B, Fornaciari G, Giusti M, Marin R, Morales R, Sangiovanni A, Belloni G, Pozzi M, Poli G, Mascoli N, Corradi C, Pioltelli P, Scalori A, Mancia G. Roffi L, et al. Among authors: donada c. Eur J Gastroenterol Hepatol. 2001 May;13(5):501-6. doi: 10.1097/00042737-200105000-00007. Eur J Gastroenterol Hepatol. 2001. PMID: 11396528 Review.

2

Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease.

Chemello L, Cavalletto D, Pontisso P, Bortolotti F, Donada C, Donadon V, Frezza M, Casarin P, Alberti A. Chemello L, et al. Among authors: donada c. Hepatology. 1993 Feb;17(2):179-82. Hepatology. 1993. PMID: 8381380

3

Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C.

Chemello L, Cavalletto L, Donada C, Bonetti P, Casarin P, Urban F, Bernardinello E, Pontisso P, Alberti A. Chemello L, et al. Among authors: donada c. Gastroenterology. 1997 Nov;113(5):1654-9. doi: 10.1053/gast.1997.v113.pm9352869. Gastroenterology. 1997. PMID: 9352869 Clinical Trial.

4

Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.

Chemello L, Cavalletto L, Casarin C, Bonetti P, Bernardinello E, Pontisso P, Donada C, Belussi F, Martinelli S, Alberti A. Chemello L, et al. Among authors: donada c. Ann Intern Med. 1996 Jun 15;124(12):1058-60. doi: 10.7326/0003-4819-124-12-199606150-00005. Ann Intern Med. 1996. PMID: 8633819

5

Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon.

Mazzaro C, Zorat F, Comar C, Nascimben F, Bianchini D, Baracetti S, Donada C, Donadon V, Pozzato G. Mazzaro C, et al. Among authors: donada c. J Rheumatol. 2003 Aug;30(8):1775-81. J Rheumatol. 2003. PMID: 12913934 Clinical Trial.

6

Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study.

Mazzaro C, Monti G, Saccardo F, Zignego AL, Ferri C, De Vita S, Gabrielli A, Lenzi M, Donada C, Galli M, Pietrogrande M, Pozzato G. Mazzaro C, et al. Among authors: donada c. Clin Exp Rheumatol. 2011 Nov-Dec;29(6):933-41. Epub 2011 Dec 22. Clin Exp Rheumatol. 2011. PMID: 22153224 Clinical Trial.

7

A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis.

Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, Cavallarin G, Bolognesi M, Donada C, Bellini B, Torboli P, Gatta A; Gruppo Triveneto per l'Ipertensione Portale. Merkel C, et al. Among authors: donada c. Gastroenterology. 2004 Aug;127(2):476-84. doi: 10.1053/j.gastro.2004.05.004. Gastroenterology. 2004. PMID: 15300580 Clinical Trial.

8

Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.

Merkel C, Marin R, Sacerdoti D, Donada C, Cavallarin G, Torboli P, Amodio P, Sebastianelli G, Bolognesi M, Felder M, Mazzaro C, Gatta A. Merkel C, et al. Among authors: donada c. Hepatology. 2000 Feb;31(2):324-9. doi: 10.1002/hep.510310210. Hepatology. 2000. PMID: 10655253 Clinical Trial.

9

The pattern of response to interferon alpha (alpha-IFN) predicts sustained response to a 6-month alpha-IFN and ribavirin retreatment for chronic hepatitis C. TVVH Study Group.

Cavalletto L, Chemello L, Donada C, Casarin P, Belussi F, Bernardinello E, Marino F, Pontisso P, Gatta A, Alberti A. Cavalletto L, et al. Among authors: donada c. J Hepatol. 2000 Jul;33(1):128-34. doi: 10.1016/s0168-8278(00)80169-5. J Hepatol. 2000. PMID: 10905596 Clinical Trial.

10

Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells.

Corona G, Toffoli G, Fabris M, Viel A, Zarrelli A, Donada C, Boiocchi M. Corona G, et al. Among authors: donada c. Eur J Cancer. 1997 Jul;33(8):1284-90. doi: 10.1016/s0959-8049(97)00121-4. Eur J Cancer. 1997. PMID: 9301457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

30 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year